Citadel Advisors
GRTS

Citadel Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Citadel Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59,800
Closed -$34.7K – 15741
2024
Q3 		$34.7K Sell
59,800
-39,300
-40% -$22K ﹤0.01% 12300
2024
Q2 		$61.2K Sell
99,100
-164,200
-62% -$139K ﹤0.01% 11541
2024
Q1 		$677K Buy
263,300
+212,800
+421% +$520K ﹤0.01% 7736
2023
Q4 		$103K Buy
50,500
+38,200
+311% +$69.7K ﹤0.01% 10897
2023
Q3 		$21.2K Sell
12,300
-3,600
-23% -$6.39K ﹤0.01% 12589
2023
Q2 		$31K Sell
15,900
-28,200
-64% -$66K ﹤0.01% 12316
2023
Q1 		$123K Buy
44,100
+25,500
+137% +$72.9K ﹤0.01% 10969
2022
Q4 		$64.2K Sell
18,600
-9,500
-34% -$27.1K ﹤0.01% 11822
2022
Q3 		$72K Sell
28,100
-40,600
-59% -$129K ﹤0.01% 11362
2022
Q2 		$166K Sell
68,700
-86,500
-56% -$227K ﹤0.01% 10880
2022
Q1 		$639K Sell
155,200
-131,000
-46% -$694K ﹤0.01% 8802
2021
Q4 		$3.68M Buy
286,200
+92,800
+48% +$1.03M ﹤0.01% 4922
2021
Q3 		$2.09M Buy
193,400
+163,900
+556% +$1.49M ﹤0.01% 6247
2021
Q2 		$269K Buy
29,500
+9,500
+48% +$87.9K ﹤0.01% 11532
2021
Q1 		$189K Buy
+20,000
New +$275K ﹤0.01% 11775

Other funds holding GRTS

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Citadel Advisors's GRTS Position: Q3 2024 in Review

Citadel Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 67,786 shares — an estimated $38K sold.

Citadel Advisors first reported a position in GRTS in Q3 2018 and held it in 22 quarters. The position peaked at $4.46M in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Citadel Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 67,786 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $38K.
  • Citadel Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
  • Citadel Advisors's Gritstone bio, Inc. Common Stock position peaked at $4.46M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.